Language

Medicine shortages: Belgium · Page 27

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 27 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 27

Belgium

Dimethyl Fumarate Teva 240 mg harde maagsapresist. caps. 56 (56 x 1) UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Dimethyl Fumarate

Notice details →
Belgium

Duloxetine Krka 60 mg harde maagsapresist. caps. 100

Nicht verfügbar · Increased demand
Active ingredient: Duloxetine

Notice details →
Belgium

Eribulin Baxter 0.44 mg/ml inj. opl. i.v. flac. 2 ml

Nicht verfügbar · Increased demand
Active ingredient: Eribulin

Notice details →
Belgium

Felodipine EG Retard 5 mg tabl. verl. afgifte 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Felodipine

Notice details →
Belgium

Finasteride EG 5 mg filmomh. tabl. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Finasteride

Notice details →
Belgium

Forzaten 20 mg - 5 mg filmomh. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Olmesartan Medoxomil; Amlodipine

Notice details →
Belgium

Lariam 250 mg tabl. 8

Nicht verfügbar · Manufacturing delay
Active ingredient: Mefloquine

Notice details →
Belgium

Lipitor 10 mg kauwtabl. 30

Nicht verfügbar · Increased demand
Active ingredient: Atorvastatin

Notice details →
Belgium

Lysotossil 10 mg omh. tabl. 30

Available again · Increased demand
Active ingredient: Cloperastine Hydrochloride

Notice details →
Belgium

Natribic 84 mg/ml inf. opl. (conc.) i.v. amp. 100 x 5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Hydrogen Carbonate

Notice details →
Belgium

Obgemsa 75 mg filmomh. tabl. 30

Available again · Increased demand
Active ingredient: Vibegron

Notice details →
Belgium

Ovitrelle 250 µg inj. opl. s.c. voorgev. spuit 0.5 ml

Nicht verfügbar · Increased demand
Active ingredient: Chorionic Gonadotrophin (HCG)

Notice details →
Belgium

Papaverine HCl Sterop 40 mg/2 ml inj. opl. i.m./i.v./s.c. amp. 10 x 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Papaverine Hydrochloride

Notice details →
Belgium

Papaverine HCl Sterop 40 mg/2 ml inj. opl. i.m./i.v./s.c. amp. 100 x 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Papaverine Hydrochloride

Notice details →
Belgium

Perindopril/Indapamide Viatris 2.5 mg - 0.625 mg filmomh. tabl. 90

Nicht verfügbar · Sonstige
Active ingredient: Indapamide; Perindopril

Notice details →
Belgium

Physio Sterop 18 mg/2 ml parent. oplosm. i.m./i.v./s.c. amp. 10 x 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Chloride

Notice details →
Belgium

Physio Sterop 18 mg/2 ml parent. oplosm. i.m./i.v./s.c. amp. 100 x 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Chloride

Notice details →
Belgium

Physio Sterop 90 mg/10 ml parent. oplosm. i.v. amp. 10 x 10 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Chloride

Notice details →
Belgium

Procaine HCl Sterop 2% 100 mg/5 ml inj. opl. i.m./s.c. amp. 10 x 5 ml

Available again · Manufacturing delay
Active ingredient: Procaine Hydrochloride

Notice details →
Belgium

Reminyl 16 mg harde caps. verl. afgifte 84

Nicht verfügbar · Delay in final product release
Active ingredient: Galantamine

Notice details →
Belgium

Ropivacaine Fresenius Kabi 7.5 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Ropivacaine Hydrochloride

Notice details →
Belgium

Seroquel 100 mg filmomh. tabl. 30

Nicht verfügbar · Manufacturing delay
Active ingredient: Quetiapine

Notice details →
Belgium

Seroquel XR 50 mg tabl. verl. afgifte 10

Nicht verfügbar · Increased demand
Active ingredient: Quetiapine

Notice details →
Belgium

Steovit Forte Citroen 1 000 mg - 800 IE kauwtabl. 90

Available again · Delay in final product release
Active ingredient: Calcium; Cholecalciferol

Notice details →
Belgium

Symtuza 800 mg - 150 mg - 200 mg - 10 mg (Abacus Medicine) filmomh. tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Darunavir ; Cobicistat; Emtricitabine; Tenofovir Alafenamide

Notice details →
Belgium

Topamax 25 mg filmomh. tabl. 60

Nicht verfügbar · Manufacturing delay
Active ingredient: Topiramate

Notice details →
Belgium

Valproate Desitin 100 mg/ml inj. opl. i.v. amp. 5 x 10 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Valproate

Notice details →
Belgium

Valproate Desitin 100 mg/ml inj. opl. i.v. amp. 5 x 3 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sodium Valproate

Notice details →
Belgium

Visipaque 270 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 100 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Iodixanol

Notice details →
Belgium

Visipaque 270 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 50 ml

Available again · Manufacturing delay
Active ingredient: Iodixanol

Notice details →
Belgium

Visipaque 320 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 200 ml

Available again · Manufacturing delay
Active ingredient: Iodixanol

Notice details →
Belgium

Visipaque 320 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 50 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Iodixanol

Notice details →
Belgium

Vitamine B6 Sterop 100 mg/2 ml or. opl./inj. opl. i.m./i.v. amp. 100 x 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Pyridoxine Hydrochloride

Notice details →
Belgium

Xadago 50 mg filmomh. tabl. 100

Available again · Increased demand
Active ingredient: Safinamide

Notice details →
Belgium

Acetylsalicylzuur Panpharma 500 mg inj. opl. (pdr. + oplosm.) i.m./i.v. flac. + amp. 6 x 500 mg + 6 x 5 ml

Nicht verfügbar · Sonstige
Active ingredient: Acetylsalicylic Acid

Notice details →
Belgium

Amelgen 400 mg ovule 15

Available again · Logistics issues (transport, customs, etc.)
Active ingredient: Progesterone

Notice details →
Belgium

Annaïs Continu 0.02 mg - 3 mg filmomh. tabl. 13 x 28 (24 + 4)

Nicht verfügbar · Manufacturing delay
Active ingredient: Drospirenone ; Ethinylestradiol

Notice details →
Belgium

Atomoxetine Arega 80 mg (Arega Pharma) harde caps. 28

Nicht verfügbar · Manufacturing delay
Active ingredient: Atomoxetine

Notice details →
Belgium

Cardioaspirine 100 mg maagsapresist. tabl. 84

Available again · Manufacturing delay
Active ingredient: Acetylsalicylic Acid

Notice details →
Belgium

Colchicine Opocalcium 1 mg tabl. 20

Nicht verfügbar · Logistics issues (transport, customs, etc.)
Active ingredient: Colchicine

Notice details →
Belgium

Cosentyx 300 mg inj. opl. s.c. voorgev. pen 3 x 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Secukinumab

Notice details →
Belgium

Daktarin 20 mg/g or. gel 40 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Miconazole

Notice details →
Belgium

Depo-Eligard 22.5 mg inj. opl. (pdr. + oplosm.) s.c. voorgev. spuit 22.5 mg

Nicht verfügbar · Manufacturing delay
Active ingredient: Leuprorelin

Notice details →
Belgium

Docetaxel Accord 80 mg/4 ml inf. opl. (conc.) i.v. flac. 4 ml

Nicht verfügbar · Increased demand
Active ingredient: Docetaxel

Notice details →
Belgium

Engerix B 20 µg/1 ml inj. susp. s.c./i.m. voorgev. spuit 1 dosis (1 ml)

Nicht verfügbar · Manufacturing delay
Active ingredient: Hepatitis B virus surface antigen (recombinant)

Notice details →
Belgium

Evra 6 mg - 600 µg transderm. pleister sachet 9

Nicht verfügbar · Logistics issues (transport, customs, etc.)
Active ingredient: Ethinylestradiol; Norelgestromin

Notice details →
Belgium

Exacyl 500 mg filmomh. tabl. 20

Nicht verfügbar · Manufacturing delay
Active ingredient: Tranexamic Acid

Notice details →
Belgium

Extencin 1 200 000 IE inj. opl. (pdr. + oplosm.) i.m. flac. + amp. 1.2 10*6 IE + 5 ml

Nicht verfügbar · Sonstige
Active ingredient: Benzylpenicillin Benzathine

Notice details →
Belgium

Fasenra 30 mg (Orifarm) inj. opl. s.c. voorgev. pen 1 ml

Nicht verfügbar · Sonstige
Active ingredient: Benralizumab

Notice details →
Belgium

Fsme-Immun 0,25 ml Junior inj. susp. i.m./s.c. voorgev. spuit 0.25 ml

Available again · Increased demand
Active ingredient: Tick-borne encephalitis virus (inactivated) antigen

Notice details →